Ivy Dwomoh
Pediatrics · New York, NYNPI 1952786659
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 220 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 39 manufacturers, the largest accounting for just 18.5% — the pattern of someone who eats at a lot of different presentations. Among pediatrics clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 220 payments — averaging $21.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$887
- Ironshore Pharmaceuticals Inc.$554
- Sanofi Pasteur Inc.$513
- Cranial Technologies, Inc$373
- Verrica Pharmaceuticals Inc.$297
- Takeda Pharmaceuticals U.S.A., Inc.$255
- plus $2K from 33 others
What the payments were for
- Food & beverage$4,807100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 41 | $887 |
| Ironshore Pharmaceuticals Inc. | 28 | $554 |
| Sanofi Pasteur Inc. | 16 | $513 |
| Cranial Technologies, Inc | 23 | $373 |
| Verrica Pharmaceuticals Inc. | 10 | $297 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $255 |
| Merck | 14 | $246 |
| Kaleo, Inc. | 13 | $237 |
| Genentech USA, Inc. | 6 | $228 |
| Sanofi-aventis U.S. LLC | 6 | $200 |
| AstraZeneca | 5 | $124 |
| Collegium Pharmaceutical, Inc. | 6 | $107 |
| Supernus Pharmaceuticals, Inc. | 3 | $72 |
| Sobi, Inc | 3 | $61 |
| Ultragenyx Pharmaceutical Inc. | 3 | $54 |
| Corium, LLC | 2 | $51 |
| Kowa Pharmaceuticals America, Inc. | 3 | $50 |
| Acadia Pharmaceuticals Inc | 2 | $47 |
| Adlon Therapeutics L.p. | 2 | $43 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $42 |
| Neurelis, Inc. | 1 | $31 |
| Seqirus USA Inc | 1 | $26 |
| Organon | 1 | $25 |
| Xeris Pharmaceuticals, Inc. | 1 | $25 |
| Nestle Healthcare Nutrition Inc. | 1 | $24 |
| Photonicare Inc | 1 | $22 |
| Shire North American Group Inc | 1 | $20 |
| Aimmune Therapeutics, Inc. | 1 | $20 |
| Novartis | 1 | $19 |
| Phadia US Inc. | 1 | $19 |
| Dermira, Inc. | 1 | $18 |
| Vertical Pharmaceuticals, LLC | 1 | $18 |
| Amneal Pharmaceuticals LLC | 1 | $17 |
| LNHC, Inc | 1 | $16 |
| Cumberland Pharmaceuticals, Inc. | 1 | $15 |
| GSK | 1 | $15 |
| Glenmark Therapeutics Inc. | 1 | $14 |
| Tris Pharma Inc | 1 | $13 |
| Qiagen, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,807 in reported general payments places this provider in the 95th percentile of 4,055 pediatrics providers in New York.
Other pediatrics in New York
- Kathryn FitzgeraldNew York$80K
- Rudolph LeibelNew York$67K
- Shakeel ModakNew York$64K
- Jean-Laurent CasanovaNew York$62K
- Randall KayeNew York$46K
- Kevin CurranNew York$35K
- Hsiang YinNew York$25K
- Jennifer TrachtenbergNew York$23K
- John LantosNew York$12K
- Stephanie ChristensenNew York$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.